je.st
news
I Called It: What's The Take Home Message?
2015-04-26 12:32:42| Biotech - Topix.net
Merck just reported 95% SVR12 data from their phase 3 clinical trial for GT1 HCV patients. With FDA breakthrough status, expect Merck's combo on the market by early 2016.
Tags: home
message
called
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||